A key resistance mechanism involves tumor-derived exosomes carrying ENPP1, which hydrolyzes extracellular cGAMP - including LL-37-bound cGAMP - thereby suppressing STING activation in immune cells and inhibiting T cell infiltration. The gene discussed is ENPP1; the disease is neoplasm.